{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,29]],"date-time":"2025-11-29T16:25:55Z","timestamp":1764433555548,"version":"3.40.5"},"reference-count":23,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,4,18]],"date-time":"2024-04-18T00:00:00Z","timestamp":1713398400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.com.au","clinicalkey.es","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Ophthalmology Case Reports"],"published-print":{"date-parts":[[2024,9]]},"DOI":"10.1016\/j.ajoc.2024.102069","type":"journal-article","created":{"date-parts":[[2024,5,3]],"date-time":"2024-05-03T16:39:34Z","timestamp":1714754374000},"page":"102069","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["Crystalline keratopathy following long-term netarsudil therapy"],"prefix":"10.1016","volume":"35","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3499-087X","authenticated-orcid":false,"given":"Olivia W.","family":"Cummings","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4441-6780","authenticated-orcid":false,"given":"Jes\u00fas M.","family":"Mel\u00e9ndez-Monta\u00f1ez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Leah","family":"Naraine","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3199-4461","authenticated-orcid":false,"given":"Leyla","family":"Yavuz Saricay","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hani","family":"El Helwe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5636-6720","authenticated-orcid":false,"given":"David","family":"Sol\u00e1-Del Valle","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ajoc.2024.102069_bib1","doi-asserted-by":"crossref","first-page":"1939","DOI":"10.2147\/OPTH.S154001","article-title":"Profile of netarsudil ophthalmic solution and its potential in the treatment of open-angle glaucoma: evidence to date","volume":"12","author":"Dasso","year":"2018","journal-title":"Clin Ophthalmol"},{"issue":"11","key":"10.1016\/j.ajoc.2024.102069_bib2","doi-asserted-by":"crossref","first-page":"1741","DOI":"10.1016\/j.ophtha.2018.04.040","article-title":"Rho kinase inhibitors as a novel treatment for glaucoma and ocular hypertension","volume":"125","author":"Tanna","year":"2018","journal-title":"Ophthalmology"},{"issue":"1","key":"10.1016\/j.ajoc.2024.102069_bib6","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1038\/s41433-019-0671-0","article-title":"New glaucoma medications: latanoprostene bunod, netarsudil, and fixed combination netarsudil-latanoprost","volume":"34","author":"Mehran","year":"2020","journal-title":"Eye"},{"key":"10.1016\/j.ajoc.2024.102069_bib7","doi-asserted-by":"crossref","DOI":"10.1155\/2022\/6925027","article-title":"Netarsudil as an adjunctive therapy: efficacy and factors contributing to a favorable IOP-lowering effect","volume":"2022","author":"Samuel","year":"2022","journal-title":"J Ophthalmol"},{"issue":"1","key":"10.1016\/j.ajoc.2024.102069_bib8","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1097\/ICL.0000000000000544","article-title":"Ocular surface disease and glaucoma medications: a clinical approach","volume":"45","author":"Zhang","year":"2019","journal-title":"Eye Contact Lens"},{"key":"10.1016\/j.ajoc.2024.102069_bib9","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.ajo.2017.11.019","article-title":"Two phase 3 clinical trials comparing the safety and efficacy of netarsudil to timolol in patients with elevated intraocular pressure: rho kinase elevated IOP treatment trial 1 and 2 (ROCKET-1 and ROCKET-2)","volume":"186","author":"Serle","year":"2018","journal-title":"Am J Ophthalmol"},{"issue":"1","key":"10.1016\/j.ajoc.2024.102069_bib10","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1186\/s13256-021-02665-0","article-title":"Rhopressa-induced corneal edema: a case report","volume":"15","author":"Chu","year":"2021","journal-title":"J Med Case Rep"},{"issue":"11","key":"10.1016\/j.ajoc.2024.102069_bib11","doi-asserted-by":"crossref","first-page":"e124","DOI":"10.1097\/IJG.0000000000001636","article-title":"Reticular epithelial edema: an uncommon side effect of ROCK\/NET inhibitor netarsudil","volume":"29","author":"Chen","year":"2020","journal-title":"J Glaucoma"},{"key":"10.1016\/j.ajoc.2024.102069_bib12","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.ajo.2020.04.002","article-title":"Reticular bullous epithelial edema in corneas treated with netarsudil: a case series","volume":"217","author":"Wisely","year":"2020","journal-title":"Am J Ophthalmol"},{"issue":"7","key":"10.1016\/j.ajoc.2024.102069_bib13","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1097\/IJG.0000000000001516","article-title":"Reticular corneal edema or corneal honeycombing in eyes treated with netarsudil: a case series","volume":"29","author":"Moumneh","year":"2020","journal-title":"J Glaucoma"},{"issue":"8","key":"10.1016\/j.ajoc.2024.102069_bib14","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1097\/ICO.0000000000002621","article-title":"Transient reticular cystic corneal epithelial edema with topical netarsudil: a case series and review","volume":"40","author":"LoBue","year":"2021","journal-title":"Cornea"},{"issue":"1","key":"10.1016\/j.ajoc.2024.102069_bib15","doi-asserted-by":"crossref","first-page":"44","DOI":"10.5005\/jp-journals-10078-1396","article-title":"Rho-kinase inhibitors in ocular diseases: a translational research journey","volume":"17","author":"Singh","year":"2023","journal-title":"J Curr Glaucoma Pract"},{"issue":"3","key":"10.1016\/j.ajoc.2024.102069_bib16","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1016\/j.survophthal.2016.11.008","article-title":"Drug-induced corneal epithelial changes","volume":"62","author":"Raizman","year":"2017","journal-title":"Surv Ophthalmol"},{"issue":"1","key":"10.1016\/j.ajoc.2024.102069_bib17","doi-asserted-by":"crossref","DOI":"10.1136\/bmjophth-2021-000943","article-title":"Drug-induced corneal deposits: an up-to-date review","volume":"7","author":"Sahyoun","year":"2022","journal-title":"BMJ Open Ophthalmol"},{"issue":"1","key":"10.1016\/j.ajoc.2024.102069_bib18","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/S0378-5173(97)00427-4","article-title":"Solubility characteristics of three fluoroquinolone ophthalmic solutions in an in vitro tear model","volume":"164","author":"Firestone","year":"1998","journal-title":"Int J Pharm"},{"issue":"3","key":"10.1016\/j.ajoc.2024.102069_bib19","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1038\/sj.eye.6702303","article-title":"Corneal deposits and topical ofloxacin\u2014the effect of polypharmacy in the management of microbial keratitis","volume":"21","author":"Mitra","year":"2007","journal-title":"Eye"},{"issue":"10","key":"10.1016\/j.ajoc.2024.102069_bib20","doi-asserted-by":"crossref","first-page":"1701","DOI":"10.1016\/S0886-3350(01)00893-8","article-title":"Ciprofloxacin microprecipitates and macroprecipitates in the human corneal epithelium","volume":"27","author":"Eiferman","year":"2001","journal-title":"J Cataract Refract Surg"},{"year":"2023","series-title":"PubChem Compound Summary for CID 66599893, Netarsudil","key":"10.1016\/j.ajoc.2024.102069_bib21"},{"issue":"11","key":"10.1016\/j.ajoc.2024.102069_bib22","doi-asserted-by":"crossref","DOI":"10.1001\/jamaophthalmol.2023.2949","article-title":"Symptomatic netarsudil-induced verticillata","volume":"141","author":"Rivera","year":"2023","journal-title":"JAMA Ophthalmology"},{"issue":"11","key":"10.1016\/j.ajoc.2024.102069_bib23","doi-asserted-by":"crossref","DOI":"10.3390\/jcm9113524","article-title":"Effects of netarsudil on actin-driven cellular functions in normal and glaucomatous trabecular meshwork cells: a live imaging study","volume":"9","author":"Keller","year":"2020","journal-title":"J Clin Med"},{"issue":"4","key":"10.1016\/j.ajoc.2024.102069_bib24","doi-asserted-by":"crossref","DOI":"10.3390\/jcm12041270","article-title":"Investigation of the pathogenic mechanism of ciprofloxacin in aortic aneurysm and dissection by an integrated proteomics and network pharmacology strategy","volume":"12","author":"Chen","year":"2023","journal-title":"J Clin Med"},{"year":"2019","series-title":"Full Prescribing Information: NDA 208254\/S-003 [press Release]. Food and Drug Administration","key":"10.1016\/j.ajoc.2024.102069_bib25"},{"key":"10.1016\/j.ajoc.2024.102069_bib26","article-title":"Corneal opacity induced by antiglaucoma agents other than brimonidine tartrate","volume":"2020","author":"Kasuya","year":"2020","journal-title":"Case Rep Ophthalmol Med"}],"container-title":["American Journal of Ophthalmology Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2451993624000793?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2451993624000793?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,11,18]],"date-time":"2024-11-18T00:42:30Z","timestamp":1731890550000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2451993624000793"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9]]},"references-count":23,"alternative-id":["S2451993624000793"],"URL":"https:\/\/doi.org\/10.1016\/j.ajoc.2024.102069","relation":{},"ISSN":["2451-9936"],"issn-type":[{"type":"print","value":"2451-9936"}],"subject":[],"published":{"date-parts":[[2024,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Crystalline keratopathy following long-term netarsudil therapy","name":"articletitle","label":"Article Title"},{"value":"American Journal of Ophthalmology Case Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ajoc.2024.102069","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"102069"}}